{"id":"CHEMBL1071","canonicalSmiles":"O=C(O)CCc1nc(-c2ccccc2)c(-c2ccccc2)o1","inchiKey":"OFPXSFXSNFPTHF-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"OXAPROZIN","yearOfFirstApproval":1992,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Daypro","Oxaprozin"],"synonyms":["NSC-310839","Oxaprozin","WY-21,743","WY-21743"],"crossReferences":{"DailyMed":["oxaprozin"],"PubChem":["11110656","11110657","144203610","170464987","26719634","26747622","4254158","455291","50106813","50106814","85230870","90340983"],"Wikipedia":["Oxaprozin"],"drugbank":["DB00991"],"chEBI":["7822"]},"childChemblIds":["CHEMBL1200463"],"count":1,"approvedIndications":["EFO_0005755"],"linkedTargets":{"rows":["ENSG00000073756","ENSG00000095303"],"count":2},"linkedDiseases":{"rows":["EFO_0005755"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1992 and is indicated for rheumatic disease. This drug has a black box warning from the FDA."}
{"id":"CHEMBL1082","canonicalSmiles":"CC1(C)S[C@@H]2[C@H](NC(=O)[C@H](N)c3ccc(O)cc3)C(=O)N2[C@H]1C(=O)O","inchiKey":"LSQZJLSUYDQPKJ-NJBDSQKTSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"AMOXICILLIN","yearOfFirstApproval":1974,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Amix 125","Amix 250","Amix 500","Amopen","Amoram","Amoxi-Inject","Amoxi-Tabs","Amoxicillin","Amoxicillin pediatric","Amoxicilline","Amoxident 250","Amoxident 500","Amoxil","Amoxil fiztab","Amoxil sf","Amoxycillin","Amoxymed","Amrit","Aquacil","Biomox","Dedoxil","Dispermox","Flemoxin solutab","Galenamox","Larotid","Moxatag","Polymox","Respillin","Robamox","Sumox","Trimox","Utimox","Vetremox","Wymox","Zoxycil 250","Zoxycil 500"],"synonyms":["Amoxicillin","Amoxicillin hydrate","Amoxicillin trihydrate","Amoxicilline","Amoxycillin","BRL 2333","BRL-2333","NSC-277174"],"crossReferences":{"DailyMed":["amoxicillin"],"PubChem":["144204854","144204855","50124271","855939"],"Wikipedia":["Amoxicillin"],"drugbank":["DB01060"],"chEBI":["2676"]},"childChemblIds":["CHEMBL2105950"],"count":49,"approvedIndications":["EFO_0003106","EFO_0003103","EFO_0000771","EFO_0007486","EFO_0000544","DOID_7551","EFO_0004992","HP_0011110","EFO_0004607","MONDO_0002258"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1974 and has 10 approved and 39 investigational indications."}
{"id":"CHEMBL1083390","canonicalSmiles":"O=S(=O)(c1ccccc1)c1cnc2c(N3CCNCC3)cccc2c1","inchiKey":"JJZFWROHYSMCMU-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"INTEPIRDINE","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["GSK-742457","GSK742457","Intepirdine","RVT-101","SB-742457","Sb-742457"],"crossReferences":{"Wikipedia":["SB-742,457"],"drugbank":["DB12680"]},"count":2,"linkedTargets":{"rows":["ENSG00000158748"],"count":1},"linkedDiseases":{"rows":["HP_0000726","EFO_0000249"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL1095930","canonicalSmiles":"CO/N=C(\\C(=O)N[C@@H]1C(=O)N2C(C(=O)OC(C)OC(C)=O)=C(COC(N)=O)CS[C@H]12)c1ccco1","inchiKey":"KEJCWVGMRLCZQQ-YJBYXUATSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CEFUROXIME AXETIL","yearOfFirstApproval":1987,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Ceftin","Cefuroxime axetil","Zinnat"],"synonyms":["CCI 15641","CCI-15641","Cefuroxime 1-acetoxyethyl ester","Cefuroxime axetil"],"crossReferences":{"DailyMed":["cefuroxime%20axetil"],"chEBI":["3516"]},"count":2,"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1987 and has 2 investigational indications."}
{"id":"CHEMBL113948","canonicalSmiles":"CCCC[C@@H](C=O)NC(=O)O[C@H](Cc1ccccc1)C(C)C","inchiKey":"ZLZXUNHJWVLGTE-DLBZAZTESA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL113948","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07592"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1180725","canonicalSmiles":"CC(C)[N+](C)(CCOC(=O)C1c2ccccc2Oc2ccccc21)C(C)C","inchiKey":"VVWYOYDLCMFIEM-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PROPANTHELINE","yearOfFirstApproval":1953,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Propantheline"],"crossReferences":{"DailyMed":["propantheline%20bromide"],"PubChem":["11111683","11112101","90340675"],"drugbank":["DB00782"],"chEBI":["8481"]},"childChemblIds":["CHEMBL1240"],"count":1,"approvedIndications":["EFO_0010282"],"linkedTargets":{"rows":["ENSG00000133019","ENSG00000181072","ENSG00000168539"],"count":3},"linkedDiseases":{"rows":["EFO_0010282","EFO_0004253","EFO_1000781"],"count":3},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1953 and is indicated for gastrointestinal disease."}
{"id":"CHEMBL118218","canonicalSmiles":"CC1=C(CO)C2=C(C)C3(CC3)[C@@](C)(O)C(=O)C2=C1","inchiKey":"NICJCIQSJJKZAH-AWEZNQCLSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"IROFULVEN","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Irofulven","MGI 114","MGI-114","NSC-683863"],"crossReferences":{"PubChem":["520035"],"Wikipedia":["Irofulven"],"drugbank":["DB05786"]},"count":19,"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 19 investigational indications."}
{"id":"CHEMBL119521","canonicalSmiles":"CCCCCCP(=O)(O)OCC","inchiKey":"XPLOQMVUXWZLET-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ETHYL HYDROGEN HEXYLPHOSPHONATE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Hexyl-Phosphonic Acid Monoethyl Ester"],"crossReferences":{"drugbank":["DB04321"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1198650","canonicalSmiles":"N=C(N)c1ccc(CNC(=O)[C@@H]2CCCN2C(=O)CCC2CCCC2)cc1","inchiKey":"BNCHHUFGEOJCNH-SFHVURJKSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1198650","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07095"]},"childChemblIds":["CHEMBL609619"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1200622","canonicalSmiles":"C[C@@H](/C=C/[C@@H](C)[C@H]1CC[C@H]2/C(=C/C=C3C[C@@H](O)C[C@H](O)C3)CCC[C@@]21C)C(C)(C)O","inchiKey":"BPKAHTKRCLCHEA-UBFJEZKGSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PARICALCITOL","yearOfFirstApproval":1998,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Paricalcitol","Zemplar"],"synonyms":["COMPOUND 49510","COMPOUND-49510","Paricalcitol"],"crossReferences":{"DailyMed":["paricalcitol"],"PubChem":["144206540"],"Wikipedia":["Paricalcitol"],"drugbank":["DB00910"],"chEBI":["7931"]},"count":18,"approvedIndications":["EFO_0003884","EFO_0005754"],"linkedTargets":{"rows":["ENSG00000111424"],"count":1},"linkedDiseases":{"rows":["EFO_0002618","EFO_0003086","HP_0002901","EFO_1001173","EFO_0000616","HP_0000093","EFO_0000401","MONDO_0007254","EFO_1000657","EFO_0004194","EFO_1002048","MONDO_0008315","EFO_0005754","EFO_0003896","EFO_1000044","EFO_0008506","EFO_0002517","EFO_0003884","EFO_0004272","EFO_0001378","EFO_0004285","MONDO_0024880","EFO_0001360"],"count":23},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1998 and is indicated for chronic kidney disease and parathyroid disease and has 16 investigational indications."}
{"id":"CHEMBL1200679","canonicalSmiles":"[Cl-].[Cl-].[Zn+2]","inchiKey":"JIAARYAFYJHUJI-UHFFFAOYSA-L","drugType":"Small molecule","blackBoxWarning":false,"name":"ZINC CHLORIDE","yearOfFirstApproval":1986,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Zinc chloride"],"crossReferences":{"DrugCentral":["4344"],"PubChem":["144211809"],"Wikipedia":["Zinc_chloride"],"drugbank":["DB14533"],"chEBI":["49976"]},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1986."}
{"id":"CHEMBL1200686","canonicalSmiles":"CC[C@@H]1/C=C(\\C)C[C@H](C)C[C@H](OC)[C@H]2O[C@@](O)(C(=O)C(=O)N3CCCC[C@H]3C(=O)O[C@H](/C(C)=C/[C@@H]3CC[C@H](Cl)[C@H](OC)C3)[C@H](C)[C@@H](O)CC1=O)[C@H](C)C[C@@H]2OC","inchiKey":"KASDHRXLYQOAKZ-XDSKOBMDSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"PIMECROLIMUS","yearOfFirstApproval":2001,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Elidel"],"synonyms":["Pimecrolimus","SDZ ASM 981","SDZ ASM-981","SDZ-ASM 981","SDZ-ASM-981"],"crossReferences":{"DailyMed":["pimecrolimus"],"Wikipedia":["Pimecrolimus"],"drugbank":["DB00337"]},"count":10,"approvedIndications":["HP_0000964","EFO_0000274"],"linkedTargets":{"rows":["ENSG00000088832"],"count":1},"linkedDiseases":{"rows":["MONDO_0026045","EFO_1000906","EFO_1000724","HP_0000964","EFO_1000764","MONDO_0002406","EFO_1001305","EFO_0004208","EFO_0000274","EFO_1000726","EFO_0008517","Orphanet_634"],"count":12},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2001 and is indicated for atopic eczema and eczema and has 8 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL1200922","canonicalSmiles":"CCC(C)C(C)(COC(N)=O)COC(N)=O","inchiKey":"LEROTMJVBFSIMP-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"MEBUTAMATE","yearOfFirstApproval":1982,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Dormate"],"synonyms":["Mebutamate","W-583"],"crossReferences":{"PubChem":["170465233"],"Wikipedia":["Mebutamate"],"drugbank":["DB06797"]},"count":1,"approvedIndications":["EFO_0005230"],"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1982 and is indicated for anxiety."}
{"id":"CHEMBL1200953","canonicalSmiles":"CCCC(=O)O[C@]1(C(=O)COC(=O)CC)CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3[C@@H](O)C[C@@]21C","inchiKey":"FOGXJPFPZOHSQS-AYVLZSQQSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"HYDROCORTISONE PROBUTATE","yearOfFirstApproval":1997,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Pandel"],"synonyms":["Hydrocortisone buteprate","Hydrocortisone butyrate propionate","Hydrocortisone probutat","Hydrocortisone probutate","TS 408","TS-408"],"crossReferences":{"DailyMed":["hydrocortisone%20probutate"],"PubChem":["144206491"],"drugbank":["DB14543"],"chEBI":["31675"]},"linkedTargets":{"rows":["ENSG00000113580"],"count":1},"linkedDiseases":{"rows":["EFO_0000676","EFO_0000274"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1997."}
{"id":"CHEMBL1201170","canonicalSmiles":"O=C([O-])CC(O)(CC(=O)[O-])C(=O)[O-].[Li+].[Li+].[Li+]","inchiKey":"WJSIUCDMWSDDCE-UHFFFAOYSA-K","drugType":"Small molecule","blackBoxWarning":true,"name":"LITHIUM CITRATE","yearOfFirstApproval":1980,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Lithium citrate"],"crossReferences":{"Wikipedia":["Lithium_citrate"],"drugbank":["DB14507"],"chEBI":["64735"]},"childChemblIds":["CHEMBL2103738"],"linkedTargets":{"rows":["ENSG00000082701","ENSG00000105723","ENSG00000133731"],"count":3},"linkedDiseases":{"rows":["EFO_0005407"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1980. This drug has a black box warning from the FDA."}
{"id":"CHEMBL1201484","drugType":"Small molecule","blackBoxWarning":false,"name":"SODIUM POLYSTYRENE SULFONATE","yearOfFirstApproval":1958,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Kalexate","Kayexalate","Kionex","Resonium a","Sodium polystyrene sulfonate"],"synonyms":["Polystyrene Sulfonate","Polystyrene sulfonate","Sodium polystyrene sulfonate"],"crossReferences":{"DailyMed":["sodium%20polystyrene%20sulfonate"],"DrugCentral":["4487"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1958 and has 1 investigational indication."}
{"id":"CHEMBL1201494","drugType":"Unknown","blackBoxWarning":false,"name":"SODIUM FERRIC GLUCONATE COMPLEX","yearOfFirstApproval":1999,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Ferrlecit","Sodium ferric gluconate complex in sucrose"],"synonyms":["Ferric sodium gluconate complex","Sodium ferric gluconate complex"],"crossReferences":{"DailyMed":["sodium%20ferric%20gluconate%20complex"]},"count":2,"description":"Unknown drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1999 and has 2 investigational indications."}
{"id":"CHEMBL1201651","drugType":"Protein","blackBoxWarning":true,"name":"PROTAMINE SULFATE","yearOfFirstApproval":1969,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Prosulf","Protamine Sulphate","Protamine sulfate"],"synonyms":["Protamine","Protamine sulfate"],"crossReferences":{"DailyMed":["protamine%20sulfate"],"DrugCentral":["5034"]},"description":"Protein drug with a maximum clinical trial phase of IV that was first approved in 1969. This drug has a black box warning from the FDA."}
{"id":"CHEMBL1201716","drugType":"Protein","blackBoxWarning":false,"name":"MECASERMIN","yearOfFirstApproval":2005,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Increlex","Myotrophin"],"synonyms":["CEP-151","Insulin-like growth factor i","Mecasermin","Mecasermin recombinant"],"crossReferences":{"DailyMed":["mecasermin%20recombinant"],"DrugCentral":["5009"],"Wikipedia":["Mecasermin"]},"count":14,"linkedTargets":{"rows":["ENSG00000140443"],"count":1},"linkedDiseases":{"rows":["Orphanet_48652","Orphanet_648","HP_0001507","MONDO_0002177","EFO_0004260","Orphanet_778","EFO_0000384","Orphanet_181393","EFO_0003885","HP_0004322","GO_0007568","EFO_0000253","EFO_1001348","EFO_0000400","EFO_1001434","EFO_0004215"],"count":16},"description":"Protein drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2005 and has 14 investigational indications."}
{"id":"CHEMBL1206161","canonicalSmiles":"O=C(O)[C@H]1C/C(=C2/CCN(c3ccccc3)C2=O)c2ccc(Cl)cc2N1","inchiKey":"XDKRVNKVAKCFGW-WXWBBQJKSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1206161","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB15099"]},"childChemblIds":["CHEMBL232357"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1213271","canonicalSmiles":"Cn1c(N)nc2ncc(-c3ccccc3)cc21","inchiKey":"UQVKZNNCIHJZLS-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"2-AMINO-1-METHYL-6- PHENYLIMIDAZO[4,5- B]PYRIDINE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"Wikipedia":["2-Amino-1-methyl-6-phenylimidazo(4,5-b)pyridine"],"drugbank":["DB08398"],"chEBI":["76290"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1232858","canonicalSmiles":"CCCCCCCCCCC[C@@H](O)CC(=O)O","inchiKey":"ATRNZOYKSNPPBF-CYBMUJFWSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"3-Hydroxymyristic Acid","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["3-Hydroxymyristic Acid"],"crossReferences":{"drugbank":["DB02767"],"chEBI":["42539"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1233953","canonicalSmiles":"OC[C@H]1O[C@H](O[C@@H]2[C@@H](CO)O[C@H](O[C@@H]3[C@@H](CO)N/C(=N/O)[C@H](O)[C@H]3O)[C@H](O)[C@H]2O)[C@H](O)[C@@H](O)[C@@H]1O","inchiKey":"AHRWQUNEPBVNOT-IVJVVCOPSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1233953","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB01922"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1234613","canonicalSmiles":"NC(=O)c1ccc[n+]([C@@H]2O[C@H](COP(=O)([O-])OP(=O)(O)OC[C@H]3O[C@@H](n4cnc5c(N)ncnc54)[C@H](O)[C@@H]3O)[C@@H](O)[C@H]2O)c1","inchiKey":"BAWFJGJZGIEFAR-NNYOXOHSSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"NADIDE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["CO-I","DPN","Diphosphopyridine nucleotide","NAD","NAD+","Nadide","Nicotinamide Adinine Dinucleotide","Nicotinamide adenine dinucleotide"],"crossReferences":{"PubChem":["144203872"],"drugbank":["DB14128"],"chEBI":["44215"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1235491","canonicalSmiles":"Cc1cn([C@H]2C[C@H](OP(=O)(O)O)[C@@H](COP(=O)(O)O)O2)c(=O)[nH]c1=O","inchiKey":"CSNCBOPUCJOHLS-XLPZGREQSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1235491","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB04205"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1236157","canonicalSmiles":"Cc1cn([C@H]2C[C@H](O)[C@@H](COP(=O)(O)OP(=O)(O)OP(=O)(O)OP(=O)(O)OP(=O)(O)OC[C@H]3O[C@@H](n4cnc5c(N)ncnc54)[C@H](O)[C@@H]3O)O2)c(=O)[nH]c1=O","inchiKey":"JCFDSPQTEMXXLO-SLFMBYJQSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1236157","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB03280"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1236189","canonicalSmiles":"O[As](O)O","inchiKey":"GCPXMJHSNVMWNM-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TRIHYDROXYARSENITE(III)","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB04456"],"chEBI":["49900"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1257030","canonicalSmiles":"O=C(O)c1nn(Cc2ccc(Cl)cc2Cl)c2ccccc12","inchiKey":"WDRYRZXSPDWGEB-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"LONIDAMINE","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Lonidamine"],"crossReferences":{"PubChem":["11111381","11114165","11532966","124880557","144203732","144209504","170466647","50104921","50104922","85231114","90341155"],"drugbank":["DB06266"],"chEBI":["50138"]},"count":2,"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL1262","canonicalSmiles":"Clc1ccc(CO/N=C(\\Cn2ccnc2)c2ccc(Cl)cc2Cl)c(Cl)c1","inchiKey":"QRJJEGAJXVEBNE-HKOYGPOVSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"OXICONAZOLE","yearOfFirstApproval":1988,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Oxiconazole","Oxistat","Oxizole"],"crossReferences":{"DailyMed":["oxiconazole%20nitrate"],"Wikipedia":["Oxiconazole"],"drugbank":["DB00239"],"chEBI":["7825"]},"childChemblIds":["CHEMBL1200836"],"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1988."}
{"id":"CHEMBL1292","canonicalSmiles":"CC(C)/N=c1\\cc2n(-c3ccc(Cl)cc3)c3ccccc3nc-2cc1Nc1ccc(Cl)cc1","inchiKey":"WDQPAMHFFCXSNU-BGABXYSRSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CLOFAZIMINE","yearOfFirstApproval":1986,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Lamprene"],"synonyms":["Clofazimine","G 30320","G-30320","NSC-141046"],"crossReferences":{"PubChem":["11112506","121269827"],"Wikipedia":["Clofazimine"]},"count":8,"approvedIndications":["EFO_0001054"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1986 and is indicated for leprosy and has 7 investigational indications."}
{"id":"CHEMBL134022","canonicalSmiles":"COc1cccc(-c2nc3c(C(N)=O)cccc3[nH]2)c1","inchiKey":"NVVWVYYHTKCIAE-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL134022","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB04010"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1397","canonicalSmiles":"CC[C@@H]([C@H](C)O)n1ncn(-c2ccc(N3CCN(c4ccc(OC[C@@H]5CO[C@@](Cn6cncn6)(c6ccc(F)cc6F)C5)cc4)CC3)cc2)c1=O","inchiKey":"RAGOYPUPXAKGKH-XAKZXMRKSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"POSACONAZOLE","yearOfFirstApproval":2006,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Noxafil"],"synonyms":["Noxafil","Posaconazole","SCH 56592","SCH-56592"],"crossReferences":{"DailyMed":["posaconazole"],"Wikipedia":["Posaconazole"],"drugbank":["DB01263"],"chEBI":["64355"]},"childChemblIds":["CHEMBL4303216","CHEMBL1908108"],"count":12,"approvedIndications":["MONDO_0002026"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2006 and is indicated for candidiasis and has 11 investigational indications."}
{"id":"CHEMBL14193","canonicalSmiles":"O=Cc1ccc(O)cc1","inchiKey":"RGHHSNMVTDWUBI-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"4-HYDROXYBENZALDEHYDE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Para-Hydroxybenzaldehyde","p-hydroxybenzaldehyde"],"crossReferences":{"PubChem":["124899140"],"Wikipedia":["4-Hydroxybenzaldehyde"],"drugbank":["DB03560"],"chEBI":["17597"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL147806","canonicalSmiles":"CC(C)(C)NCc1ccc(Nc2ccnc3cc(Cl)ccc23)cc1O","inchiKey":"ZVMMVSSEAMUNGI-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"GSK-369796","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["GSK369796","Gsk-369796"],"childChemblIds":["CHEMBL515899"],"count":1,"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL1485","canonicalSmiles":"N=C(N)NCCC[C@H](N)C(=O)O","inchiKey":"ODKSFYDXXFIFQN-BYPYZUCNSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ARGININE","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Arginine","L-arginine","NSC-206269"],"crossReferences":{"PubChem":["11110746","11113629","170465748","50104526","90341198"],"Wikipedia":["Arginine"],"drugbank":["DB00125"],"chEBI":["16467"]},"count":36,"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) and has 36 investigational indications."}
{"id":"CHEMBL1505","canonicalSmiles":"CN(C)CCc1c[nH]c2ccc(CS(=O)(=O)N3CCCC3)cc12","inchiKey":"WKEMJKQOLOHJLZ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ALMOTRIPTAN","yearOfFirstApproval":2001,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Almotriptan","LAS 31416","LAS-31416"],"crossReferences":{"DailyMed":["almotriptan%20malate"],"PubChem":["170465288","174006290","26748976"],"Wikipedia":["Almotriptan"],"drugbank":["DB00918"],"chEBI":["520985"]},"childChemblIds":["CHEMBL1200521"],"count":1,"approvedIndications":["EFO_0003821"],"linkedTargets":{"rows":["ENSG00000135312","ENSG00000179546","ENSG00000179097"],"count":3},"linkedDiseases":{"rows":["EFO_0003821","EFO_0003843"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 2001 and is indicated for migraine disorder."}
{"id":"CHEMBL1549","canonicalSmiles":"C[C@]12C[C@H](O)[C@H]3[C@@H](CCC4=CC(=O)CC[C@@]43C)[C@@H]1CC[C@]2(O)C(=O)COC(=O)CCC1CCCC1","inchiKey":"DLVOSEUFIRPIRM-KAQKJVHQSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"HYDROCORTISONE CYPIONATE","yearOfFirstApproval":1955,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Cortef"],"synonyms":["Hydrocortisone Cypionate","Hydrocortisone cipionate","Hydrocortisone cyclopentylpropionate","Hydrocortisone cypionate","NSC-10721"],"crossReferences":{"PubChem":["75847"],"drugbank":["DB14541"],"chEBI":["5783"]},"count":3,"approvedIndications":["EFO_0009552","EFO_0005752"],"linkedTargets":{"rows":["ENSG00000113580"],"count":1},"linkedDiseases":{"rows":["EFO_0000729","EFO_0009552","HP_0004798","EFO_0005752","MONDO_0009410"],"count":5},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1955 and is indicated for hemorrhoid and eye inflammation and has 1 investigational indication."}
{"id":"CHEMBL1579","canonicalSmiles":"C[C@@H]1C[C@H]2[C@@H]3C[C@H](F)C4=CC(=O)C=C[C@]4(C)[C@H]3[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)CO","inchiKey":"MKPDWECBUAZOHP-AFYJWTTESA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PARAMETHASONE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Paramethasone"],"crossReferences":{"Wikipedia":["Paramethasone"],"drugbank":["DB01384"],"chEBI":["7922"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1587","canonicalSmiles":"CN1C(CSCC(F)(F)F)Nc2cc(Cl)c(S(N)(=O)=O)cc2S1(=O)=O","inchiKey":"CYLWJCABXYDINA-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"POLYTHIAZIDE","yearOfFirstApproval":1961,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Nephril","Renese"],"synonyms":["P-2525","Polythiazide"],"crossReferences":{"PubChem":["144206688","170465068"],"Wikipedia":["Polythiazide"],"drugbank":["DB01324"],"chEBI":["8327"]},"count":1,"approvedIndications":["EFO_0000319"],"linkedTargets":{"rows":["ENSG00000070915"],"count":1},"linkedDiseases":{"rows":["EFO_0000319"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1961 and is indicated for cardiovascular disease."}
{"id":"CHEMBL161084","canonicalSmiles":"O=C(c1ccco1)N(c1cnccn1)C1CCN(CCc2ccccc2)CC1","inchiKey":"BJZZDOLVVLWFHN-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"MIRFENTANIL","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Mirfentanil"],"crossReferences":{"drugbank":["DB09175"]},"childChemblIds":["CHEMBL2448139"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL163","canonicalSmiles":"CC(C)c1nc(CN(C)C(=O)N[C@H](C(=O)N[C@@H](Cc2ccccc2)C[C@H](O)[C@H](Cc2ccccc2)NC(=O)OCc2cncs2)C(C)C)cs1","inchiKey":"NCDNCNXCDXHOMX-XGKFQTDJSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"RITONAVIR","yearOfFirstApproval":1996,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Norvir","Ritonavir"],"synonyms":["A-84538","ABBOTT-84538","ABT-538","NSC-693184","Norvir","Ritonavir","Ritonavir related compounds mixture"],"crossReferences":{"DailyMed":["ritonavir"],"PubChem":["144206522","144206981","170464891","26719904","29215414"],"Wikipedia":["Ritonavir"],"drugbank":["DB00503"],"chEBI":["45409"]},"count":25,"approvedIndications":["EFO_0004220","EFO_0000764","EFO_0000180","EFO_0003047","EFO_0000763"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1996 and has 5 approved and 20 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL1639","canonicalSmiles":"COCCCOc1cc(C[C@@H](C[C@H](N)[C@@H](O)C[C@H](C(=O)NCC(C)(C)C(N)=O)C(C)C)C(C)C)ccc1OC","inchiKey":"UXOWGYHJODZGMF-QORCZRPOSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"ALISKIREN","yearOfFirstApproval":2007,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Rasilez"],"synonyms":["Aliskiren","SPP-100","SPP100"],"crossReferences":{"DailyMed":["aliskiren%20hemifumarate"],"Wikipedia":["Aliskiren"],"drugbank":["DB09026"],"chEBI":["601027"]},"childChemblIds":["CHEMBL559358","CHEMBL1667","CHEMBL3545059","CHEMBL3508698"],"count":17,"approvedIndications":["EFO_0000319"],"linkedTargets":{"rows":["ENSG00000143839"],"count":1},"linkedDiseases":{"rows":["EFO_0003086","EFO_0000275","EFO_0000401","EFO_0000373","EFO_0000319","EFO_1001461","EFO_0004194","Orphanet_558","EFO_0000537","EFO_0003914","EFO_0003896","EFO_0000195","MONDO_0021661","EFO_0003144","EFO_0003884","EFO_1002032","EFO_0000612","EFO_0001360","EFO_0000400","EFO_0009321","EFO_0005672"],"count":21},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2007 and is indicated for cardiovascular disease and has 16 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL1673159","canonicalSmiles":"CC1CCC(C(=O)N(c2cc(-c3ccccc3)sc2C(=O)[O-])C2CCC(O)CC2)CC1.[Na+]","inchiKey":"SSERCMQZZYTNBY-UHFFFAOYSA-M","drugType":"Small molecule","blackBoxWarning":false,"name":"VCH-759","maximumClinicalTrialPhase":1,"parentId":"CHEMBL1741078","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["VCH-759","Vch-759"],"count":1,"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL1713","canonicalSmiles":"CN(C)CCCN1c2ccccc2Sc2ccc(Cl)cc21.Cl","inchiKey":"FBSMERQALIEGJT-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"CHLORPROMAZINE HYDROCHLORIDE","yearOfFirstApproval":1957,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL71","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Chloractil","Chlorazine","Chlorpromazine hydrochloride","Chlorpromazine hydrochloride intensol","Largactil","Largactil fte","Promapar","Rimazine","Sonazine","Thorazine"],"synonyms":["Chlorpromazine HCl","Chlorpromazine hydrochloride","NSC-17479"],"crossReferences":{"DailyMed":["chlorpromazine%20hydrochloride"],"PubChem":["144210835","14743551","26751622","50106001","50125717","56422870","855926"],"chEBI":["3649"]},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1957. This drug has a black box warning from the FDA."}
{"id":"CHEMBL1738990","canonicalSmiles":"CCC(=O)O[C@@](Cc1ccccc1)(c1ccccc1)[C@@H](C)CN(C)C","inchiKey":"XLMALTXPSGQGBX-PGRDOPGGSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"LEVOPROPOXYPHENE","yearOfFirstApproval":1962,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Levopropoxyphene"],"crossReferences":{"drugbank":["DB06793"]},"childChemblIds":["CHEMBL1593906"],"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1962."}
{"id":"CHEMBL1741037","canonicalSmiles":"C[C@@H](Oc1ccc(Oc2cnc3ccc(Cl)cc3n2)cc1)C(=O)O","inchiKey":"NUQZXROIVGBRGR-SNVBAGLBSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"R(+)XK469","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["R(+)xk469"],"crossReferences":{"PubChem":["525927"]},"childChemblIds":["CHEMBL1433897"],"count":2,"description":"Small molecule drug with a maximum clinical trial phase of I (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL1743003","drugType":"Antibody","blackBoxWarning":false,"name":"CONATUMUMAB","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["AMG 655","AMG-655","Conatumumab","TRAIL-R2 MAB","TRAIL-R2-MAB","TRAIL-R2MAB XG1-048","XG1-048"],"count":8,"linkedTargets":{"rows":["ENSG00000120889"],"count":1},"linkedDiseases":{"rows":["EFO_0002618","EFO_1001480","EFO_1000044","MONDO_0002158","MONDO_0015686","MONDO_0008170","EFO_0000403","EFO_1001968","EFO_1001469","EFO_0000183","EFO_0003060"],"count":11},"description":"Antibody drug with a maximum clinical trial phase of II (across all indications) and has 8 investigational indications."}
{"id":"CHEMBL1750","canonicalSmiles":"Nc1nc(Cl)nc2c1ncn2[C@@H]1O[C@H](CO)[C@@H](O)[C@@H]1F","inchiKey":"WDDPHFBMKLOVOX-AYQXTPAHSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CLOFARABINE","yearOfFirstApproval":2004,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Clolar","Evoltra"],"synonyms":["Clofarabine","Clolar"],"crossReferences":{"DailyMed":["clofarabine"],"PubChem":["144205735","170465145"],"Wikipedia":["Clofarabine"],"drugbank":["DB00631"],"chEBI":["681569"]},"count":21,"approvedIndications":["EFO_0000616","EFO_0000311"],"linkedTargets":{"rows":["ENSG00000177084","ENSG00000101868","ENSG00000146143","ENSG00000062822","ENSG00000167325","ENSG00000148229","ENSG00000198056","ENSG00000100479","ENSG00000077514","ENSG00000106628","ENSG00000014138","ENSG00000175482"],"count":12},"linkedDiseases":{"rows":["EFO_0000198","MONDO_0013730","EFO_0000616","MONDO_0000873","EFO_1001779","EFO_0005803","EFO_0000220","MONDO_0019457","EFO_0000222","EFO_0005952","MONDO_0003541","EFO_0000224","EFO_0000311","EFO_0000565","EFO_1000318","MONDO_0015760","EFO_0000339","EFO_0000096","EFO_0000095","EFO_0000574","EFO_0001378","EFO_0000183","Orphanet_2781","MONDO_0020743"],"count":24},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2004 and is indicated for cancer and neoplasm and has 19 investigational indications."}
{"id":"CHEMBL1779046","canonicalSmiles":"O=C(O[C@H]1CN2CCC1CC2)N(Cc1cc(F)c(F)c(F)c1)c1cccc(F)c1","inchiKey":"UXZDMXYRRQJIBJ-IBGZPJMESA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TARAFENACIN","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Svt-40776","Tarafenacin"],"count":1,"linkedTargets":{"rows":["ENSG00000133019"],"count":1},"linkedDiseases":{"rows":["EFO_1000781"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL1812161","canonicalSmiles":"CC(C)=CCC/C(C)=C/CC/C(C)=C/CC[C@@](C)(O)CCC1=C(C)C(=O)C(C)=C(C)C1=O","inchiKey":"LNOVHERIIMJMDG-XZXLULOTSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"VATIQUINONE","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["(R)-Alpha-Tocotrienol Quinone","EPI-743","Vatiquinone"],"crossReferences":{"drugbank":["DB11917"]},"count":8,"linkedTargets":{"rows":["ENSG00000181019"],"count":1},"linkedDiseases":{"rows":["Orphanet_68380","EFO_0003756","Orphanet_506","EFO_1001254","EFO_0002508","EFO_0004895","Orphanet_778","Orphanet_699","Orphanet_95"],"count":9},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 8 investigational indications."}
{"id":"CHEMBL191413","canonicalSmiles":"CC(C)Cc1ccc([C@@H](C)C(=O)NS(C)(=O)=O)cc1","inchiKey":"KQDRVXQXKZXMHP-LLVKDONJSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"REPARIXIN","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["DF 1681Y","DF-1681Y","Df-1681y","Reparixin"],"crossReferences":{"PubChem":["144205825"],"drugbank":["DB12614"]},"childChemblIds":["CHEMBL1527147"],"count":4,"linkedTargets":{"rows":["ENSG00000180871","ENSG00000163464"],"count":2},"linkedDiseases":{"rows":["EFO_0002687","EFO_0001359","MONDO_0007254","EFO_0000342"],"count":4},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 4 investigational indications."}
{"id":"CHEMBL1940832","canonicalSmiles":"O=CNc1cc([C@@H](O)CNCCc2ccc(NC[C@H](O)c3ccccc3)cc2)ccc1O","inchiKey":"BMKINZUHKYLSKI-DQEYMECFSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"MILVETEROL","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["GSK-159797","GSK159797","Gsk159797","Milveterol","TD3327"],"childChemblIds":["CHEMBL2107356"],"count":1,"linkedTargets":{"rows":["ENSG00000169252"],"count":1},"linkedDiseases":{"rows":["EFO_0000341"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL1951032","canonicalSmiles":"COc1c(Nc2ccc(S(C)(=O)=O)nc2C)ncnc1OC1CCN(C(=O)OC(C)C)CC1","inchiKey":"WPDCHTSXOPUOII-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ADP-597","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Adp-597","JNJ-38431055","Jnj-38431055"],"crossReferences":{"drugbank":["DB12084"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL2097002","canonicalSmiles":"O=[Se](=O)(O)O","inchiKey":"QYHFIVBSNOWOCQ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SELENIC ACID","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB11068"],"chEBI":["18170"]},"childChemblIds":["CHEMBL114503"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2103975","canonicalSmiles":"CC(C)[C@@H]1NC(=O)[C@H](CCCCN)NC(=O)[C@H](Cc2c[nH]c3ccccc23)NC(=O)[C@@H](Cc2ccc(O)cc2)NC(=O)[C@@H](NC(=O)[C@H](N)Cc2ccccc2)CSSC[C@@H](C(=O)N[C@@H](Cc2c[nH]c3ccccc23)C(N)=O)NC1=O","inchiKey":"SWXOGPJRIDTIRL-KTJGOPLGSA-N","drugType":"Protein","blackBoxWarning":false,"name":"VAPREOTIDE","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Sanvar"],"synonyms":["BMY-41606","Bmy-41606","DP-05-094","RC-160","Vapreotide","Vapreotide acetate"],"childChemblIds":["CHEMBL2218872"],"count":1,"linkedTargets":{"rows":["ENSG00000162009","ENSG00000278195","ENSG00000180616"],"count":3},"linkedDiseases":{"rows":["MP_0001914","EFO_0005323","EFO_0009545","EFO_0000666"],"count":4},"description":"Protein drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL2104095","canonicalSmiles":"C[N+](C)(C)CCO.O=C([O-])c1ccccc1O","inchiKey":"UDKCHVLMFQVBAA-UHFFFAOYSA-M","drugType":"Small molecule","blackBoxWarning":false,"name":"CHOLINE SALICYLATE","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Arthropan","Dinnefords"],"synonyms":["Choline salicylate"],"crossReferences":{"drugbank":["DB14006"]},"count":2,"approvedIndications":["HP_0001945","EFO_0003843"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) and is indicated for pain and fever."}
{"id":"CHEMBL2104807","canonicalSmiles":"CCCCc1cc2c(=O)c(C(=O)OC)c[nH]c2cc1OCc1ccccc1","inchiKey":"NNOPDLNHPOLRRE-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"NEQUINATE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["AY-20,385","ICI 55,052","Methyl benzoquate","Neoquate","Nequinate"],"crossReferences":{"PubChem":["144206498"],"drugbank":["DB11433"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2104980","canonicalSmiles":"Cl.N#Cc1c[nH]c2c(C(=O)N3CCN(CCc4ccc(F)cc4)CC3)cccc12","inchiKey":"UYGNZRVLPYZLTF-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PRUVANSERIN HYDROCHLORIDE","maximumClinicalTrialPhase":0,"parentId":"CHEMBL1215661","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["LSN2420586","Pruvanserin hydrochloride"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2105107","canonicalSmiles":"C[C@H](CC#CC(C)(C)O)[C@H]1CC[C@@H]2/C(=C/C=C3C[C@@H](O)C[C@H](O)C3)CCC[C@@]21C","inchiKey":"HHGRMHMXKPQNGF-WNSNRMDMSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"INECALCITOL","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Inecalcitol","TX-522","Tx-522"],"crossReferences":{"drugbank":["DB04796"]},"count":2,"linkedTargets":{"rows":["ENSG00000111424"],"count":1},"linkedDiseases":{"rows":["EFO_0000339","EFO_0000222"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL2105364","canonicalSmiles":"CC1(C)S[C@@H]2[C@H](NC(=O)Cc3ccccc3)C(=O)N2[C@H]1C(=O)[O-].CC1(C)S[C@@H]2[C@H](NC(=O)Cc3ccccc3)C(=O)N2[C@H]1C(=O)[O-].[Ca+2]","inchiKey":"PEWXRXAGXPYMIB-ANPZCEIESA-L","drugType":"Small molecule","blackBoxWarning":false,"name":"PENICILLIN CALCIUM","maximumClinicalTrialPhase":0,"parentId":"CHEMBL29","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Penicillin calcium"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2105372","canonicalSmiles":"CCN(CC)CC(C)OC(=O)C1CCCCC1(O)C1CCCCC1","inchiKey":"XPYLKZZOBVLVHB-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ROCIVERINE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Rociverine"],"count":1,"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL2105630","canonicalSmiles":"CO[C@H]1/C=C\\C=C(/C)C(=O)NC2=CC(=O)C(NCCN(C)C)=C(C[C@@H](C)C[C@H](OC)[C@H](O)[C@@H](C)/C=C(\\C)[C@@H]1OC(N)=O)C2=O.Cl","inchiKey":"DFSYBWLNYPEFJK-IHLRWNDRSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ALVESPIMYCIN HYDROCHLORIDE","maximumClinicalTrialPhase":1,"parentId":"CHEMBL383824","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Alvespimycin hydrochloride","BMS-826476","KOS-1022"],"count":3,"description":"Small molecule drug with a maximum clinical trial phase of I (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL2105633","canonicalSmiles":"COc1cc2c(cc1OC)[C@@H]1C[C@H](N)[C@@H](N3C[C@@H](CF)CC3=O)CN1CC2.Cl.Cl","inchiKey":"DDKJYXSAKVWFLS-LSKWAPIISA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CARMEGLIPTIN DIHYDROCHLORIDE","maximumClinicalTrialPhase":0,"parentId":"CHEMBL591118","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Carmegliptin dihydrochloride","RO4876904-001"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2107389","canonicalSmiles":"CCCCCC(=O)O[C@]1(C(C)=O)CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@@H]4[C@H]3CC[C@@]21C","inchiKey":"XURCMZMFZXXQDJ-UKNJCJGYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"GESTONORONE CAPROATE","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Depostat"],"synonyms":["Gestonorone caproate","Gestonorone hexanoate","Gestronol","SH 582"],"crossReferences":{"drugbank":["DB14677"]},"description":"Small molecule drug with a maximum clinical trial phase of IV."}
{"id":"CHEMBL2107608","canonicalSmiles":"Cn1c(=O)c2c(ncn2CCNCC(O)c2ccc(O)c(O)c2)n(C)c1=O","inchiKey":"WMCMJIGLYZDKRN-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"THEODRENALINE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Theodrenaline"],"crossReferences":{"drugbank":["DB12927"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL2107763","canonicalSmiles":"Cc1cc(=O)oc2cc(O[C@@H]3SC[C@@H](O)[C@H](O)[C@H]3O)ccc12","inchiKey":"JRHNIQQUVJOPQC-AQNFWKISSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ODIPARCIL","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Odiparcil"],"crossReferences":{"PubChem":["170466179"],"drugbank":["DB06609"]},"count":2,"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL2108187","drugType":"Antibody","blackBoxWarning":false,"name":"CLENOLIXIMAB","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["CE9?4PE","Clenoliximab","IDEC-151"],"description":"Antibody drug with a maximum clinical trial phase of II."}
{"id":"CHEMBL2108280","drugType":"Oligonucleotide","blackBoxWarning":false,"name":"CENERSEN","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Cenersen"],"count":2,"description":"Oligonucleotide drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL2108693","drugType":"Unknown","blackBoxWarning":false,"name":"SYRUP","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Simple syrup","Syrup"],"count":10,"description":"Unknown drug with a maximum clinical trial phase of III (across all indications) and has 10 investigational indications."}
{"id":"CHEMBL2108774","drugType":"Unknown","blackBoxWarning":false,"name":"PLATELET CONCENTRATE","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Platelet concentrate"],"count":1,"description":"Unknown drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL2109637","drugType":"Antibody","blackBoxWarning":false,"name":"HUHMFG1","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["AS-1402","AS1402","HUHMFG1","Huhmfg1","MOAB HuHMFG1","R1550","Therex","humanized IgG1 monoclonal antibody","humanized human milk fat globule-1 monoclonal antibody"],"count":2,"linkedTargets":{"rows":["ENSG00000185499"],"count":1},"linkedDiseases":{"rows":["MONDO_0008170","MONDO_0007254","MONDO_0002087","EFO_0000305"],"count":4},"description":"Antibody drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL220808","canonicalSmiles":"Fc1ccc(-c2cncc(CNC[C@H]3CCc4ccccc4O3)c2)cc1","inchiKey":"HKFMQJUJWSFOLY-OAQYLSRUSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SARIZOTAN","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["EMD-77697","Sarizotan"],"crossReferences":{"drugbank":["DB06454"]},"childChemblIds":["CHEMBL2146110"],"count":2,"linkedTargets":{"rows":["ENSG00000178394","ENSG00000069696","ENSG00000149295","ENSG00000151577"],"count":4},"linkedDiseases":{"rows":["EFO_0004280","EFO_0002508","Orphanet_778"],"count":3},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL225546","canonicalSmiles":"C[C@]12CCc3c(ccc4cc(O)ccc34)[C@@H]1CCC2=O","inchiKey":"PDRGHUMCVRDZLQ-WMZOPIPTSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"EQUILENIN","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Equilenin"],"crossReferences":{"Wikipedia":["Equilenin"],"drugbank":["DB03515"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL233970","canonicalSmiles":"N=C1NC(=O)/C(=C/c2ccc(-c3ccc(S(N)(=O)=O)c(C(F)(F)F)c3)o2)S1","inchiKey":"RGVVHQNJKUNSFQ-WDZFZDKYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL233970","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07538"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2364659","drugType":"Antibody","blackBoxWarning":false,"name":"ONTUXIZUMAB","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["MORAB-004","Ontuxizumab"],"count":3,"linkedTargets":{"rows":["ENSG00000174807"],"count":1},"linkedDiseases":{"rows":["EFO_0000616","EFO_1001968","EFO_0002617"],"count":3},"description":"Antibody drug with a maximum clinical trial phase of II (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL2365940","canonicalSmiles":"C[N+]1(C)[C@H]2CC[C@@H]1C[C@@H](CC(C#N)(c1ccccc1)c1ccccc1)C2","inchiKey":"BKLAJZNVMHLXAP-AGYIDARRSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DAROTROPIUM","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"childChemblIds":["CHEMBL2308782"],"linkedTargets":{"rows":["ENSG00000180720","ENSG00000184984","ENSG00000133019","ENSG00000181072","ENSG00000168539"],"count":5},"linkedDiseases":{"rows":["EFO_0000341"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of II."}
{"id":"CHEMBL237370","canonicalSmiles":"O=C(/C=C/c1ccc(Cl)cc1Cl)NO","inchiKey":"LHTLDFWBUPYUDR-DUXPYHPUSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CINNAMIC ACID HYDROXAMATE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["2,4-Dichlorocinnamic Hydroxamate","2,4-Dichlorocinnamic Hydroxamic Acid","2,4-Dichlorocinnamichydroxamic Acid","2,4-Dichlorocinnamyl Hydroxamic Acid","Cinnamic Acid Hydroxamate"],"crossReferences":{"drugbank":["DB07818"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2426701","canonicalSmiles":"CC1=CC(=O)[C@H]2C[C@@H]1C2(C)C","inchiKey":"DCSCXTJOXBUFGB-JGVFFNPUSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"LEVOVERBENONE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Levoverbenone"],"crossReferences":{"PubChem":["144211748"],"drugbank":["DB13391"],"chEBI":["78316"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL255696","canonicalSmiles":"CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO","inchiKey":"VBICKXHEKHSIBG-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"GLYCERYL MONOSTEARATE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Eastman 600"],"synonyms":["Glyceryl monostearate"],"crossReferences":{"PubChem":["144205713","144209771","144211421","170465522","26757948"],"Wikipedia":["Glycerol_monostearate"],"drugbank":["DB11250"],"chEBI":["75555"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL267099","canonicalSmiles":"Nc1ncnc2c1ccn2[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O","inchiKey":"HDZZVAMISRMYHH-KCGFPETGSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TUBERCIDIN","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Tubercidin"],"crossReferences":{"PubChem":["26757019","47193881"],"drugbank":["DB03172"],"chEBI":["48267"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL270164","canonicalSmiles":"Cc1nnc(-c2ccc(C)c(-c3ccc(C(=O)Nc4cccc(C#N)c4)cc3)c2)o1","inchiKey":"PMMLSQFPBFKLHH-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"GW607117X","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["GW607117X"],"crossReferences":{"PubChem":["124349856"],"drugbank":["DB07833"],"chEBI":["49627"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL275084","canonicalSmiles":"CC(C)Cn1c(=O)n(C)c(=O)c2nc[nH]c21","inchiKey":"APIXJSLKIYYUKG-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ISOBUTYLMETHYLXANTHINE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["2-Acetoxy-Benzoic Acid","3-Isobutyl-Methylxanthine"],"crossReferences":{"PubChem":["11111325","26732612","26747540","26747541","50106451","90340936"],"Wikipedia":["IBMX"],"drugbank":["DB07954"],"chEBI":["34795"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL277945","canonicalSmiles":"CCN1CCCC1CNC(=O)c1cc(S(=O)(=O)CC)ccc1OC","inchiKey":"UNRHXEPDKXPRTM-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SULTOPRIDE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Sultopride","Sultopride hydrochloride"],"crossReferences":{"Wikipedia":["Sultopride"],"drugbank":["DB13273"],"chEBI":["9356"]},"childChemblIds":["CHEMBL3182384"],"count":1,"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL279229","canonicalSmiles":"COc1ccccc1N1CCN(CCCNc2cc(=O)n(C)c(=O)n2C)CC1","inchiKey":"ICMGLRUYEQNHPF-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"URAPIDIL","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["NSC-310405","Urapidil"],"crossReferences":{"PubChem":["104171260","11111935","11111936","11114211","144203849","26752246","90341686","99361071"],"Wikipedia":["Urapidil"],"drugbank":["DB12661"]},"childChemblIds":["CHEMBL1256716"],"count":3,"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL279816","canonicalSmiles":"ClC=C(Cl)Cl","inchiKey":"XSTXAVWGXDQKEL-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TRICHLOROETHYLENE","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Chlorylen","Trilene"],"synonyms":["Trichloroethylene"],"crossReferences":{"PubChem":["144204652","144209741","17389697","26752936"],"Wikipedia":["Trichloroethylene"],"drugbank":["DB13323"],"chEBI":["16602"]},"description":"Small molecule drug with a maximum clinical trial phase of IV."}
{"id":"CHEMBL285527","canonicalSmiles":"O=S(=O)(O)c1cccc2cccc(Nc3ccccc3)c12","inchiKey":"FWEOQOXTVHGIFQ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL285527","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["124896729","47193709"],"Wikipedia":["8-Anilinonaphthalene-1-sulfonic_acid"],"drugbank":["DB04474"],"chEBI":["39708"]},"childChemblIds":["CHEMBL1530925"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL286494","canonicalSmiles":"Cc1cc(O)c2c(=O)c3c(O)cc(O)c4c5c(O)cc(O)c6c(=O)c7c(O)cc(C)c8c1c2c(c34)c(c78)c65","inchiKey":"BTXNYTINYBABQR-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"HYPERICIN","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Hypericin","NSC-407313","SGX301"],"crossReferences":{"PubChem":["124892429","26755796","26756738","579322","580981"],"Wikipedia":["Hypericin"],"drugbank":["DB13014"],"chEBI":["5835"]},"count":2,"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL291962","canonicalSmiles":"CC(C)C[C@H](N)C(=O)O","inchiKey":"ROHFNLRQFUQHCH-YFKPBYRVSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"LEUCINE","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["E641","FEMA NO. 3297","L-leucine","Leucine","NSC-46709"],"crossReferences":{"PubChem":["4253012"],"Wikipedia":["Leucine"],"drugbank":["DB00149"],"chEBI":["15603"]},"count":7,"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 7 investigational indications."}
{"id":"CHEMBL3039597","canonicalSmiles":"CNC(C)[C@@H]1CC[C@@H](N)[C@@H](O[C@@H]2[C@@H](N)C[C@@H](N)[C@H](O[C@H]3OC[C@](C)(O)[C@H](NC)[C@H]3O)[C@H]2O)O1.CN[C@@H]1[C@@H](O)[C@@H](O[C@@H]2[C@@H](O)[C@H](O[C@H]3O[C@H](C(C)N)CC[C@H]3N)[C@@H](N)C[C@H]2N)OC[C@]1(C)O.CN[C@@H]1[C@@H](O)[C@@H](O[C@@H]2[C@@H](O)[C@H](O[C@H]3O[C@H](CN)CC[C@H]3N)[C@@H](N)C[C@H]2N)OC[C@]1(C)O","inchiKey":"NPEFREDMMVQEPL-RWPARATISA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"GENTAMICIN","yearOfFirstApproval":1970,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Gentamicin","SCH-9724","Uromycine"],"crossReferences":{"DailyMed":["gentamicin%20sulfate"],"DrugCentral":["4265"]},"childChemblIds":["CHEMBL3039594"],"count":25,"approvedIndications":["EFO_0000771","EFO_1001888"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1970 and is indicated for bacterial disease and eye infection and has 23 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL306823","canonicalSmiles":"O=C([O-])C(Cl)Cl.[Na+]","inchiKey":"LUPNKHXLFSSUGS-UHFFFAOYSA-M","drugType":"Small molecule","blackBoxWarning":false,"name":"SODIUM DICHLOROACETATE","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Ceresine"],"synonyms":["CMI X-11S","CPC-211","DCA","Sodium dichloroacetate"],"crossReferences":{"PubChem":["144207122","144211711","50112986"]},"count":6,"linkedTargets":{"rows":["ENSG00000067992","ENSG00000004799","ENSG00000152256","ENSG00000005882"],"count":4},"linkedDiseases":{"rows":["EFO_0003777","EFO_0001361","Orphanet_765","EFO_1000036","EFO_0000519","EFO_0000181"],"count":6},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) and has 6 investigational indications."}
{"id":"CHEMBL308148","canonicalSmiles":"CC(=O)NC1(c2ccccc2)CCN(CC[C@H](CN(C)C(=O)c2ccccc2)c2ccc(Cl)c(Cl)c2)CC1","inchiKey":"PGKXDIMONUAMFR-AREMUKBSSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SAREDUTANT","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Saredutant"],"crossReferences":{"Wikipedia":["Saredutant"],"drugbank":["DB06660"]},"count":3,"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL3181841","canonicalSmiles":"Cl.Cn1cc(C(=O)[C@@H]2CCc3[nH]cnc3C2)c2ccccc21","inchiKey":"XIXYTCLDXQRHJO-RFVHGSKJSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"RAMOSETRON HYDROCHLORIDE","maximumClinicalTrialPhase":3,"parentId":"CHEMBL1643895","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Ramosetron hydrochloride","YM-060","YM060","Ym060"],"crossReferences":{"PubChem":["144205994","170465928"]},"count":1,"linkedTargets":{"rows":["ENSG00000149305","ENSG00000186090","ENSG00000178084","ENSG00000186038","ENSG00000166736"],"count":5},"linkedDiseases":{"rows":["EFO_0000555"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL3183067","canonicalSmiles":"CC(=O)OC(C)OC(=O)C(C)c1ccc(-c2ccccc2)c(F)c1","inchiKey":"ALIVXCSEERJYHU-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL3183067","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["144206486","144206574"],"drugbank":["DB14938"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3186392","canonicalSmiles":"CC(C)(O/N=C(\\C(=O)N[C@@H]1C(=O)N2C(C(=O)[O-])=C(C[n+]3ccccc3)CS[C@H]12)c1csc(N)n1)C(=O)O.O.O.O.O.O","inchiKey":"NMVPEQXCMGEDNH-TZVUEUGBSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL3186392","maximumClinicalTrialPhase":0,"parentId":"CHEMBL44354","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["144204348"],"chEBI":["3509"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3187455","canonicalSmiles":"CCCCCCCN(CC)CCCC(O)c1ccc(NS(C)(=O)=O)cc1.CCCCCCCN(CC)CCCC(O)c1ccc(NS(C)(=O)=O)cc1.O=C(O)C=CC(=O)O","inchiKey":"PCIOHQNIRPWFMV-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL3187455","maximumClinicalTrialPhase":0,"parentId":"CHEMBL533","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["50126320"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL323348","canonicalSmiles":"COC(=O)c1ccccc1C(=O)OC","inchiKey":"NIQCNGHVCWTJSM-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DIMETHYL PHTHALATE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Dimethyl phthalate","Dimethylphthalate","Methyl phthalate"],"crossReferences":{"PubChem":["144209343","144211362","17389503","225144196","26752743"],"Wikipedia":["Dimethyl_phthalate"],"drugbank":["DB13336"],"chEBI":["4609"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL3237547","canonicalSmiles":"O=C1N[C@H](O)CCN1[C@@H]1O[C@H](CO)[C@@H](O)C1(F)F","inchiKey":"VUDZSIYXZUYWSC-DBRKOABJSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CEDAZURIDINE","yearOfFirstApproval":2020,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["ASTX-727 COMPONENT CEDAZURIDINE","ASTX727 COMPONENT CEDAZURIDINE","Cedazuridine","E-7727","E7727"],"count":2,"approvedIndications":["EFO_0000198"],"linkedTargets":{"rows":["ENSG00000158825"],"count":1},"linkedDiseases":{"rows":["EFO_0000198","EFO_0000616"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2020 and is indicated for myelodysplastic syndrome and has 1 investigational indication."}
{"id":"CHEMBL3250773","canonicalSmiles":"O=S(=O)(O)O.[2H]C(C)(N)Cc1ccccc1","inchiKey":"SOFQDLYSFOWTJX-RKMPQLHESA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL3250773","maximumClinicalTrialPhase":0,"parentId":"CHEMBL405","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3264002","canonicalSmiles":"CNS(=O)(=O)Nc1nccc(Cc2c(C)c3ccc(Oc4ncccn4)cc3oc2=O)c1F","inchiKey":"LMMJFBMMJUMSJS-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CKI-27","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["CKI-27","RG-7304","Ro-5126766"],"crossReferences":{"drugbank":["DB15254"],"chEBI":["78825"]},"childChemblIds":["CHEMBL3264004"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3274483","canonicalSmiles":"O=C1N[11C](=O)C(c2ccccc2)(c2ccccc2)N1","inchiKey":"CXOFVDLJLONNDW-HSGWXFLFSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL3274483","maximumClinicalTrialPhase":0,"parentId":"CHEMBL16","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3301571","drugType":"Cell","blackBoxWarning":false,"name":"VESIGENURTUCEL-L","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["HS-410","UM-UC-3-gp96-Ig-HLA-A1","Vesigenurtucel-l"],"count":1,"description":"Cell drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL3301589","drugType":"Antibody","blackBoxWarning":false,"name":"ENFORTUMAB VEDOTIN","yearOfFirstApproval":2019,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Padcev"],"synonyms":["AGS-22CE","AGS-22M6E","AGS-22ME","AGS-22MSE","ASG-22ME","Enfortumab vedotin","Enfortumab vedotin-ejfv"],"count":5,"linkedTargets":{"rows":["ENSG00000143217"],"count":1},"linkedDiseases":{"rows":["EFO_0000616","EFO_0003863","EFO_0008528","MONDO_0020654","EFO_0000311","MONDO_0001187"],"count":6},"description":"Antibody drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2019 and has 5 investigational indications."}
{"id":"CHEMBL330829","canonicalSmiles":"CCOC(=O)/C=C1\\SC(N2CCCCC2)C(=O)N1C","inchiKey":"ZCKKHYXUQFTBIK-KTKRTIGZSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ETOZOLIN","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Etozolin","W 2900A"],"crossReferences":{"drugbank":["DB08982"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3338194","canonicalSmiles":"CS(=O)(=O)c1ccc(-n2cc(Cl)c(OC3CCN(c4ncc(Cl)cn4)CC3)cc2=O)c(F)c1","inchiKey":"OGIAVRWXUPYGGC-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BMS-903452","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Bms-903452"],"crossReferences":{"drugbank":["DB11773"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL334167","canonicalSmiles":"Cn1sc(=O)c2cc(S(N)(=O)=O)ccc21","inchiKey":"DFPYCCVFXMWMJM-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL334167","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB03294"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3354350","canonicalSmiles":"CCCOC(=O)Cc1ccc(OCC(=O)N(CC)CC)c(OCC)c1","inchiKey":"QPUVKSKJCNGSGT-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"AZD-3043","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["AZD-3043","AZD3043","Azd 3043","Azd-3043","Azd3043","THRX-918661"],"crossReferences":{"drugbank":["DB12576"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL339427","canonicalSmiles":"COc1cc2c3cc1Oc1cc(ccc1O)C[C@@H]1c4c(cc(OC)c(O)c4Oc4ccc(cc4)C[C@@H]3N(C)CC2)CC[N+]1(C)C","inchiKey":"JFJZZMVDLULRGK-URLMMPGGSA-O","drugType":"Small molecule","blackBoxWarning":false,"name":"TUBOCURARINE","yearOfFirstApproval":1945,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Tubocurarine"],"crossReferences":{"PubChem":["26756599"],"drugbank":["DB01199"],"chEBI":["9774"]},"childChemblIds":["CHEMBL292280","CHEMBL3989821","CHEMBL1687"],"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1945."}
{"id":"CHEMBL34259","canonicalSmiles":"CN(Cc1cnc2nc(N)nc(N)c2n1)c1ccc(C(=O)N[C@@H](CCC(=O)O)C(=O)O)cc1","inchiKey":"FBOZXECLQNJBKD-ZDUSSCGKSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"METHOTREXATE","yearOfFirstApproval":1953,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Amethopterin","Ebetrex","Emtexate high-pot","Emtexate pf","Folex","Maxtrex","Methotrexate","Metoject","Mexate","Otrexup","Otrexup pfs","Rasuvo","Reditrex","Rheumatrex","Trexall","Zlatal"],"synonyms":["ADX-2191","Abitrexate","Amethopterin","CL 14377","CL-14377","EMT-25299","Folex","Methotrexate","Methylaminopterin","Mexate","Mexate-AQ","NSC-740","R-9985","R-methotrexate","TCMDC-123832","TCMDC-125488","TCMDC-125858","Trexall"],"crossReferences":{"DailyMed":["methotrexate","methotrexate%20sodium"],"PubChem":["11113978","124886991","144204495","144210589","170464688","26752120","26752121","26752122","50104777","50104778","56463665","67627","90340825"],"Wikipedia":["Methotrexate"],"drugbank":["DB00563"],"chEBI":["44185"]},"childChemblIds":["CHEMBL4572304","CHEMBL3244648","CHEMBL1376974"],"count":145,"approvedIndications":["EFO_0000616","EFO_0003869","EFO_0000685","MONDO_0000873","EFO_1001494","EFO_0000220","MONDO_0007254","MONDO_0000870","EFO_0000540","EFO_0000305","EFO_0002609","EFO_0000311","EFO_0000676","EFO_1001051"],"linkedTargets":{"rows":["ENSG00000228716"],"count":1},"linkedDiseases":{"rows":["EFO_0000637","EFO_0005952","EFO_1001951","EFO_0006803","EFO_1000318","EFO_0000339","EFO_0000096","EFO_0002690","EFO_1000956","MONDO_0002974","Orphanet_3319","EFO_0000588","EFO_0000676","EFO_0004991","Orphanet_42738","MONDO_0002038","MONDO_0021054","EFO_0000198","MONDO_0013730","MONDO_0007608","EFO_0000221","EFO_0009012","MONDO_0019465","EFO_0001642","Orphanet_636","EFO_1001946","EFO_1000309","EFO_0000384","EFO_0007187","EFO_1001231","EFO_1001365","EFO_0003032","EFO_0006818","MONDO_0019472","EFO_0004284","EFO_0000574","EFO_0001378","Orphanet_231214","EFO_1000550","Orphanet_84","EFO_0000292","MONDO_0044903","MONDO_0007254","EFO_0000255","EFO_1001012","MONDO_0019541","EFO_1000298","MONDO_0003541","EFO_1001486","MONDO_0020654","EFO_0002430","EFO_0004289","EFO_0007208","EFO_0000183","EFO_0000707","Orphanet_447","MONDO_0003478","EFO_1000388","Orphanet_797","EFO_0000616","EFO_1001779","EFO_0006859","Orphanet_59305","MONDO_0019457","EFO_0001645","EFO_0000403","EFO_0003898","EFO_0000222","EFO_0003929","MONDO_0000870","EFO_0000319","HP_0031456","MONDO_0019469","EFO_0004599","EFO_0003843","EFO_0003885","EFO_1001471","EFO_0005297","EFO_0000764","EFO_1001947","MONDO_0002367","MONDO_0018906","EFO_0000557","Orphanet_2781","EFO_0000729","MONDO_0000873","EFO_0003869","EFO_0001075","Orphanet_183660","EFO_0004274","EFO_1000131","EFO_0000540","EFO_0000565","EFO_0000309","EFO_0004251","Orphanet_365","EFO_0002506","MONDO_0019460","MONDO_0019088","EFO_0000389","EFO_0000330","MONDO_0015540","EFO_1001176","EFO_0004208","EFO_1000789","EFO_1000785","EFO_0000094","EFO_0000692","EFO_0009441","EFO_0003802","EFO_1001857","EFO_0000220","MONDO_0008170","EFO_1001466","EFO_0005842","EFO_1000157","EFO_0000223","EFO_0002939","MONDO_0044881","EFO_0002429","EFO_0000224","EFO_0003025","EFO_1000784","EFO_0009708","EFO_1001209","MP_0001845","EFO_1000986","MONDO_0019474","Orphanet_811","EFO_0004192","MONDO_0100096","EFO_0003851","EFO_0000398","EFO_0000270","MONDO_0044917","EFO_0002428","EFO_1001051","EFO_0006544","EFO_0000218","MONDO_0003005","EFO_0003812","MONDO_0019471","EFO_1001494","Orphanet_232","MONDO_0004192","MONDO_0044887","EFO_0003778","EFO_1001945","EFO_0000209","HP_0001915","EFO_1001469","EFO_0000274","EFO_0000305","MONDO_0001187","EFO_0002950","EFO_1001480","EFO_0005531","Orphanet_906","EFO_0000770","EFO_1001830","MONDO_0001657","MONDO_0020743","EFO_0010580","EFO_0000717","EFO_1000158","EFO_0000685","EFO_0000313","MONDO_0016717","EFO_0000621","EFO_0002609","EFO_0000311","EFO_0000211","EFO_0009784","EFO_0001068","EFO_0000095","EFO_0005235","EFO_0006475","EFO_1001936","EFO_1002008","EFO_0000612","MONDO_0020077","EFO_0003833","EFO_0000691","EFO_0000181","MONDO_0024280","EFO_0002893","EFO_0003027","EFO_0003811"],"count":188},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1953 and has 14 approved and 131 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL3544992","drugType":"Antibody","blackBoxWarning":false,"name":"DENINTUZUMAB","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Denintuzumab","hBU12"],"description":"Antibody drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3545101","drugType":"Small molecule","blackBoxWarning":false,"name":"KRP203","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Krp203"],"count":3,"linkedTargets":{"rows":["ENSG00000170989"],"count":1},"linkedDiseases":{"rows":["EFO_0003834","EFO_0000729","EFO_0001642"],"count":3},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL3545106","drugType":"Protein","blackBoxWarning":false,"name":"TM30339","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Tm30339"],"count":1,"linkedTargets":{"rows":["ENSG00000204174"],"count":1},"linkedDiseases":{"rows":["EFO_0001073"],"count":1},"description":"Protein drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL3545164","canonicalSmiles":"C[C@@H](Oc1nnc(-c2ccncc2)n1C)c1cc(-c2cccc(Cl)c2)on1","inchiKey":"SXWHYTICXCLKDG-GFCCVEGCSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"AZD2066","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Azd 2066","Azd2066"],"crossReferences":{"drugbank":["DB12644"]},"count":6,"linkedTargets":{"rows":["ENSG00000168959"],"count":1},"linkedDiseases":{"rows":["EFO_0005762","EFO_0003948","EFO_1000783","HP_0012532","MONDO_0002009","EFO_0003843"],"count":6},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 6 investigational indications."}
{"id":"CHEMBL3545317","drugType":"Antibody","blackBoxWarning":false,"name":"REFANEZUMAB","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["GSK249320","Refanezumab"],"description":"Antibody drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3545366","canonicalSmiles":"CCn1c(=O)c(-c2cc[nH]n2)cc2c(C)nc(N)nc21","inchiKey":"RGHYDLZMTYDBDT-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"VOXTALISIB","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["SAR-245409","SAR245409","Voxtalisib","XL-765","XL765"],"crossReferences":{"drugbank":["DB12400"]},"count":12,"linkedTargets":{"rows":["ENSG00000145675","ENSG00000171608","ENSG00000105647","ENSG00000141506","ENSG00000051382","ENSG00000121879","ENSG00000105851","ENSG00000117461","ENSG00000198793"],"count":9},"linkedDiseases":{"rows":["EFO_0000616","EFO_0000095","MONDO_0003268","EFO_0000756","MONDO_0008170","MONDO_0007254","EFO_0000574","EFO_1001469","EFO_0000519","EFO_0003060","EFO_1001951","EFO_0000311"],"count":12},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 12 investigational indications."}
{"id":"CHEMBL3590187","canonicalSmiles":"CCC(=O)O[C@]1(C(=O)CO)CC[C@H]2[C@@H]3CCC4=CC(=O)CC[C@]4(C)[C@H]3CC[C@@]21C","inchiKey":"GPNHMOZDMYNCPO-PDUMRIMRSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CLASCOTERONE","yearOfFirstApproval":2020,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Breezula","Winlevi"],"synonyms":["CB-03-01","Cb-03-01","Clascoterone"],"crossReferences":{"drugbank":["DB12499"]},"count":2,"linkedTargets":{"rows":["ENSG00000169083"],"count":1},"linkedDiseases":{"rows":["EFO_0003894","EFO_0004191"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2020 and has 2 investigational indications."}
{"id":"CHEMBL3707220","canonicalSmiles":"CC/C=C\\C/C=C\\C/C=C\\C/C=C\\C/C=C\\CCCCOC(CC)C(=O)O","inchiKey":"VOGXDRFFBBLZBT-AAQCHOMXSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ICOSABUTATE","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Icosabutate","NST-4016","PRB-01022","PRC-4016"],"crossReferences":{"drugbank":["DB12990"]},"count":2,"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL3707269","canonicalSmiles":"CC[C@@H]1CN(C(=O)NCC(F)(F)F)C[C@@H]1c1cnc2cnc3[nH]ccc3n12.O.O.O.O.O=C(O)C(O)C(O)C(=O)O","inchiKey":"LATZVDXOTDYECD-UFTFXDLESA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"UPADACITINIB TARTRATE","maximumClinicalTrialPhase":2,"parentId":"CHEMBL3622821","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["ABT-494","Abt-494","Upadacitinib tartrate"],"description":"Small molecule drug with a maximum clinical trial phase of II."}
{"id":"CHEMBL3765148","canonicalSmiles":"CC1(C)S[C@@H]2[C@H](NC(=O)[C@H](C(=O)[O-])c3ccsc3)C(=O)N2[C@H]1C(=O)[O-].[K+].[K+]","inchiKey":"HOAUDXPRJLZHLI-QBGWIPKPSA-L","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL3765148","maximumClinicalTrialPhase":0,"parentId":"CHEMBL1449","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3818875","canonicalSmiles":"CNc1nc(C)nc(N[C@H]2CCC[C@@H](C(=O)NCc3ccc(C#N)cc3C(F)(F)F)C2)n1","inchiKey":"LQHDJQIMETZMPH-ZBFHGGJFSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"GSK2256294","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Gsk2256294"],"count":1,"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL3833321","drugType":"Antibody","blackBoxWarning":false,"name":"LECANEMAB","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["BAN-2401","BAN2401","Ban 2401","Ban2401","Lecanemab"],"count":1,"linkedTargets":{"rows":["ENSG00000142192"],"count":1},"linkedDiseases":{"rows":["EFO_0000249"],"count":1},"description":"Antibody drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL3833345","drugType":"Antibody","blackBoxWarning":false,"name":"BIRTAMIMAB","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Birtamimab","ELT1-01","Hu2A4","NEOD001"],"count":2,"description":"Antibody drug with a maximum clinical trial phase of III (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL3833374","drugType":"Antibody","blackBoxWarning":false,"name":"ANDECALIXIMAB","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Andecaliximab","GS-5745","GS5745"],"count":6,"linkedTargets":{"rows":["ENSG00000100985"],"count":1},"linkedDiseases":{"rows":["EFO_0000729","EFO_0000685","EFO_0000503","Orphanet_586","EFO_0000341","EFO_0000384"],"count":6},"description":"Antibody drug with a maximum clinical trial phase of III (across all indications) and has 6 investigational indications."}
{"id":"CHEMBL389767","canonicalSmiles":"N#Cc1cnn2c(NCCc3cnc[nH]3)nc(Nc3ccccc3)nc12","inchiKey":"IWUUKHQIKFHWIW-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL389767","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB08345"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL393820","canonicalSmiles":"CC(C)[C@H](N)C(=O)O[C@@H]1[C@@H](CO)O[C@@H](n2ccc(N)nc2=O)[C@]1(C)O","inchiKey":"TVRCRTJYMVTEFS-ICGCPXGVSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"VALOPICITABINE","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["NM-283","Valopicitabine"],"crossReferences":{"drugbank":["DB13920"]},"childChemblIds":["CHEMBL1743757"],"count":1,"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL3989444","canonicalSmiles":"CC[C@@H](C)C(=O)O[C@@H]1[C@H](OC(C)=O)c2c(ccc3ccc(=O)oc23)OC1(C)C","inchiKey":"GVBNSPFBYXGREE-CXWAGAITSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"VISNADINE","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Visnadine"],"crossReferences":{"drugbank":["DB13355"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL3989558","canonicalSmiles":"CCC(CO)NC(=O)[C@@H]1C=C2c3cccc4c3c(cn4C)C[C@H]2N(C)C1.O=C(O)/C=C\\C(=O)O","inchiKey":"LWYXFDXUMVEZKS-TZTNOGQLSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"METHYSERGIDE MALEATE","yearOfFirstApproval":1962,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL485253","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Sansert"],"synonyms":["Methysergide maleate"],"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1962."}
{"id":"CHEMBL3989691","canonicalSmiles":"CC1=NN(c2ccc(C)c(C)c2)C(=O)/C1=N\\Nc1cccc(-c2cccc(C(=O)O)c2)c1O.NCCO.NCCO","inchiKey":"PLILLUUXAVKBPY-SBIAVEDLSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"ELTROMBOPAG OLAMINE","yearOfFirstApproval":2008,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL461101","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Promacta","Promacta kit"],"synonyms":["Eltrombopag compd with 2-aminoethanol (1:2)","Eltrombopag olamine","SB-497115-GR"],"crossReferences":{"DailyMed":["eltrombopag%20olamine"]},"count":5,"approvedIndications":["EFO_0007160","EFO_0006927"],"linkedTargets":{"rows":["ENSG00000117400"],"count":1},"linkedDiseases":{"rows":["EFO_0000198","EFO_0007160","EFO_0004220","EFO_0006927","HP_0001873"],"count":5},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2008 and is indicated for severe aplastic anemia and autoimmune thrombocytopenic purpura and has 3 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL3989752","canonicalSmiles":"CN(C)CCC=C1c2ccccc2OCc2c1oc1ccccc21","inchiKey":"VZVRZTZPHOHSCK-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"OXETORONE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Oxetorone"],"crossReferences":{"drugbank":["DB13463"]},"childChemblIds":["CHEMBL3989638"],"count":1,"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL3989754","canonicalSmiles":"CC(C(=O)[O-])c1ccc(-c2ccccc2)c(F)c1.O.O.[Na+]","inchiKey":"GNMBMOULKUXEQF-UHFFFAOYSA-M","drugType":"Small molecule","blackBoxWarning":false,"name":"FLURBIPROFEN SODIUM","yearOfFirstApproval":1986,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL563","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Ansaid","Flurbiprofen sodium","Occufen","Ocufen","Zepolas"],"synonyms":["Flurbiprofen sodium"],"crossReferences":{"DailyMed":["flurbiprofen%20sodium"]},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1986."}
{"id":"CHEMBL3989769","drugType":"Small molecule","blackBoxWarning":true,"name":"NEOMYCIN SULFATE","yearOfFirstApproval":1957,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Biomydrin","Biosol","Cicatrene","Cicatrin","Fradiomycin Sulfate","Gppe nsl gel","Graneodin","Mycifradin","Myciguent","Naseptin","Neo-fradin","Neo-rx","Neobacrin","Neobiotic","Neomycin sulfate","Neosporin","Nivemycin","Tribiotic","Vibrocil"],"synonyms":["Fradiomycin sulfate","Neomycin b sulfate","Neomycin sulfate"],"crossReferences":{"DailyMed":["neomycin%20sulfate"]},"count":3,"approvedIndications":["MP_0001845","EFO_0000544"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1957 and is indicated for inflammation and infection and has 1 investigational indication. This drug has a black box warning from the FDA."}
{"id":"CHEMBL3989830","canonicalSmiles":"CC(C)CC(N(C)C)C1(c2ccc(Cl)cc2)CCC1.Cl.O","inchiKey":"KFNNPQDSPLWLCX-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SIBUTRAMINE HYDROCHLORIDE","yearOfFirstApproval":1997,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1419","hasBeenWithdrawn":true,"isApproved":true,"withdrawnNotice":{"countries":["Canada"," China"," European Union"," Hong Kong"," India"," New Zealand"," United States"],"classes":["Cardiotoxicity"," Neurotoxicity"],"year":2010},"tradeNames":["Meridia"],"synonyms":["BTS 54524","BTS-54524","Sibutramine hydrochloride","Sibutramine hydrochloride civ","Sibutramine hydrochloride hydrate","Sibutramine hydrochloride monohydrate"],"count":1,"linkedTargets":{"rows":["ENSG00000108576","ENSG00000103546","ENSG00000142319"],"count":3},"linkedDiseases":{"rows":["EFO_0001073"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1997 and has 1 investigational indication. It was withdrawn in Canada,  China,  European Union,  Hong Kong,  India,  New Zealand and  United States initially in 2010 due to Cardiotoxicity and  Neurotoxicity."}
{"id":"CHEMBL3989996","drugType":"Antibody","blackBoxWarning":false,"name":"PORGAVIXIMAB","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Zmapp"],"synonyms":["Porgaviximab","c2G4"],"count":1,"description":"Antibody drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL400841","canonicalSmiles":"CN(C)C(=O)[C@@H]([C@H]1CC[C@H](c2cccc3ncnn32)CC1)[C@H](N)C(=O)N1CC[C@H](F)C1","inchiKey":"ZPWDKZWKUOYOHA-UKSSEWCLSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL400841","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07135"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL415690","canonicalSmiles":"OC[C@H]1O[C@@H]2O[C@@H]3[C@@H](CO)O[C@H](O[C@@H]4[C@@H](CO)O[C@H](O[C@@H]5[C@@H](CO)O[C@H](O[C@@H]6[C@@H](CO)O[C@H](O[C@@H]7[C@@H](CO)O[C@H](O[C@@H]8[C@@H](CO)O[C@H](O[C@H]1[C@H](O)[C@H]2O)[C@H](O)[C@H]8O)[C@H](O)[C@H]7O)[C@H](O)[C@H]6O)[C@H](O)[C@H]5O)[C@H](O)[C@H]4O)[C@H](O)[C@H]3O","inchiKey":"WHGYBXFWUBPSRW-FOUAGVGXSA-N","drugType":"Oligosaccharide","blackBoxWarning":false,"name":"BETADEX","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[".beta.-cyclodextrin","Beta cyclodextrin","Betadex","E-459","E459","INS NO.459","INS-459","NSC-314334"],"crossReferences":{"PubChem":["144204568","144208204","170466376","17389955"],"drugbank":["DB03995"],"chEBI":["495055"]},"description":"Oligosaccharide drug with a maximum clinical trial phase of III."}
{"id":"CHEMBL415768","canonicalSmiles":"C=C1CC[C@H]2[C@@](C)(CC[C@@H](O)[C@@]2(C)CO)[C@@H]1CCC1=CCOC1=O","inchiKey":"GVRNTWSGBWPJGS-YSDSKTICSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DEOXYANDROGRAPHOLIDE","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["14-Deoxyandrographolide","Deoxyandrographolide"],"count":2,"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL419186","canonicalSmiles":"CC[C@@]1(O)C(=O)OCc2c1cc1n(c2=O)Cc2c-1nc1ccccc1c2/C=N/OCCN","inchiKey":"IBTISPLPBBHVSU-UVOOVGFISA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL419186","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB12124"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL420","canonicalSmiles":"N=C(N)N/N=C/c1c(Cl)cccc1Cl","inchiKey":"WDZVGELJXXEGPV-YIXHJXPBSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"GUANABENZ","yearOfFirstApproval":1982,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Guanabenz","NSC-68982","WY-8678"],"crossReferences":{"PubChem":["26751943","50104618","50104619","90341577"],"Wikipedia":["Guanabenz"],"chEBI":["5553"]},"childChemblIds":["CHEMBL1200560"],"count":1,"linkedTargets":{"rows":["ENSG00000274286","ENSG00000184160","ENSG00000150594"],"count":3},"linkedDiseases":{"rows":["EFO_0003929"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1982 and has 1 investigational indication."}
{"id":"CHEMBL4296717","canonicalSmiles":"CN(C)Cc1ccc(S(=O)(=O)n2ccc(/C=C/C(=O)NO)c2)cc1","inchiKey":"FECGNJPYVFEKOD-VMPITWQZSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"RESMINOSTAT","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["4SC-201","4sc-201","BYK-408740","BYK408740","RAS-2410","RAS2410","Resminostat"],"crossReferences":{"drugbank":["DB12392"]},"count":5,"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 5 investigational indications."}
{"id":"CHEMBL4297165","canonicalSmiles":"CCN(CC)CCCC(C)Nc1ccnc2cc(Cl)ccc12.Cl.Cl","inchiKey":"PCFGECQRSMVKCC-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHLOROQUINE HYDROCHLORIDE","yearOfFirstApproval":1949,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL76","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Aralen hydrochloride"],"synonyms":["Chloroquine hydrochloride"],"count":2,"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1949 and has 2 investigational indications."}
{"id":"CHEMBL4297256","canonicalSmiles":"CC(C)(C(=O)NC1C2CC3CC1CC(C(N)=O)(C3)C2)N1CCN(c2ccc(C(F)(F)F)cn2)CC1","inchiKey":"CLHMYBJIOZXCEX-QIGVQZHLSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ABT-384","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Abt-384"],"count":1,"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL4297313","canonicalSmiles":"CC1(C)CC(OC(=O)C2CC2)CC(C)(C)N1O","inchiKey":"ZWEXEKJLDHNLLA-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"OT-551","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Ot-551"],"crossReferences":{"drugbank":["DB05650"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL4297426","drugType":"Small molecule","blackBoxWarning":false,"name":"SAMARIUM SM-153","maximumClinicalTrialPhase":3,"parentId":"CHEMBL4300244","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Samarium sm-153","Samarium-153","Sm-153"],"count":1,"description":"Small molecule drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL4297585","canonicalSmiles":"CCCCCCC(=O)OCC(COC(=O)CCCCCC)OC(=O)CCCCCC","inchiKey":"PJHKBYALYHRYSK-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TRIHEPTANOIN","yearOfFirstApproval":2020,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Dojolvi"],"synonyms":["Triheptanoin","UX-007","UX007","Ux007"],"crossReferences":{"DailyMed":["triheptanoin"],"drugbank":["DB11677"]},"count":8,"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2020 and has 8 investigational indications."}
{"id":"CHEMBL4297674","canonicalSmiles":"CC#CC(=O)N[C@H]1CCCN(c2c(F)cc(C(N)=O)c3[nH]c(C)c(C)c23)C1","inchiKey":"VJPPLCNBDLZIFG-ZDUSSCGKSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BRANEBRUTINIB","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["BMS-986195","Bms-986195","Branebrutinib"],"crossReferences":{"drugbank":["DB15347"]},"count":1,"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL4297748","drugType":"Unknown","blackBoxWarning":false,"name":"EP-100","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["EP-100","EP-100 (PEPTIDE)","Ep-100"],"count":2,"description":"Unknown drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL4297846","drugType":"Unknown","blackBoxWarning":false,"name":"UB-421","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["UB-421","UB-421 (DB4C7 MAB)","UB421","Ub-421"],"count":2,"description":"Unknown drug with a maximum clinical trial phase of III (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL4297879","drugType":"Enzyme","blackBoxWarning":false,"name":".ALPHA.1-PROTEINASE INHIBITOR HUMAN","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[".alpha.1-antitrypsin",".alpha.1-proteinase inhibitor human","Alpha 1-antitrypsin","Alpha-1 proteinase inhibitor (human)","Alpha-1-antitrypsin","Alpha1-proteinase inhibitor","Alpha1-proteinase inhibitor (human)","Glassia","Prolastin-c"],"count":7,"description":"Enzyme drug with a maximum clinical trial phase of III (across all indications) and has 7 investigational indications."}
{"id":"CHEMBL4297899","drugType":"Unknown","blackBoxWarning":false,"name":"AZD-0156","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["AZD0156","Azd 0156","Azd-0156","Azd0156"],"count":1,"description":"Unknown drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL4297957","drugType":"Small molecule","blackBoxWarning":false,"name":"AVASOPASEM MANGANESE","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Avasopasem manganese","GC-4419","GC4419","Gc4419","M-40419","SC-72325A"],"count":4,"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 4 investigational indications."}
{"id":"CHEMBL4297993","drugType":"Unknown","blackBoxWarning":false,"name":"EMD-1201081","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Emd-1201081","HYB-2055","IMO-2055","Imo-2055"],"count":3,"description":"Unknown drug with a maximum clinical trial phase of II (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL4297999","drugType":"Unknown","blackBoxWarning":false,"name":"ISIS-333611","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["ISIS 333611","Isis 333611","Isis-333611"],"count":1,"description":"Unknown drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL431","canonicalSmiles":"CCOC(=O)[C@H](CCc1ccccc1)N[C@@H](C)C(=O)N1CC2(C[C@H]1C(=O)O)SCCS2","inchiKey":"HRWCVUIFMSZDJS-SZMVWBNQSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SPIRAPRIL","yearOfFirstApproval":1994,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Spirapril"],"crossReferences":{"Wikipedia":["Spirapril"],"drugbank":["DB01348"]},"childChemblIds":["CHEMBL1200831"],"count":1,"approvedIndications":["EFO_0000319"],"linkedTargets":{"rows":["ENSG00000159640"],"count":1},"linkedDiseases":{"rows":["EFO_0000319","EFO_0000537"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1994 and is indicated for cardiovascular disease."}
{"id":"CHEMBL431733","canonicalSmiles":"CNC(=O)[C@H]1O[C@@H](n2cnc3c(NCc4cccc(I)c4)nc(Cl)nc32)[C@H](O)[C@@H]1O","inchiKey":"IPSYPUKKXMNCNQ-PFHKOEEOSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"NAMODENOSON","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["CF-102","CF102","CI-IB-MECA","CL-IB-MECA","Cf102","Chloro-IB-MECA","Namodenoson"],"crossReferences":{"PubChem":["26752072","56463287"],"drugbank":["DB12885"]},"count":3,"linkedTargets":{"rows":["ENSG00000282608"],"count":1},"linkedDiseases":{"rows":["EFO_0004220","EFO_0003095","EFO_0000182"],"count":3},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL434","canonicalSmiles":"CC(C)NCC(O)c1ccc(O)c(O)c1","inchiKey":"JWZZKOKVBUJMES-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ISOPROTERENOL","yearOfFirstApproval":1956,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["A-21","Isoprenaline","Isoproterenol","Isoproterenol dl-form","NSC-33791","NSC-9975"],"crossReferences":{"DailyMed":["isoproterenol%20hydrochloride"],"PubChem":["104171176","144203723","170464679","26752240","50104946","50111114","90340610"],"Wikipedia":["Isoprenaline"],"drugbank":["DB01064"],"chEBI":["64317"]},"childChemblIds":["CHEMBL3989521","CHEMBL1711"],"count":6,"approvedIndications":["HP_0006536","EFO_0000319"],"linkedTargets":{"rows":["ENSG00000169252","ENSG00000043591","ENSG00000188778"],"count":3},"linkedDiseases":{"rows":["EFO_0000759","HP_0006536","EFO_0000275","Orphanet_230","EFO_0004253","EFO_1000645","EFO_0005252","EFO_0000319"],"count":8},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1956 and is indicated for cardiovascular disease and airway obstruction and has 4 investigational indications."}
{"id":"CHEMBL44083","canonicalSmiles":"CCNCCCNCCCNCCCNCC","inchiKey":"UMJJGDUYVQCBMC-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BIS(ETHYL)NORSPERMINE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["11113515"],"drugbank":["DB06445"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL44618","canonicalSmiles":"ClC(Cl)Cl","inchiKey":"HEDRZPFGACZZDS-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHLOROFORM","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":true,"isApproved":true,"withdrawnNotice":{"countries":["United States"]},"tradeNames":[],"synonyms":["Chloroform"],"crossReferences":{"PubChem":["144209692","17389970"],"Wikipedia":["Chloroform"],"drugbank":["DB11387"],"chEBI":["35255"]},"description":"Small molecule drug with a maximum clinical trial phase of IV. It was withdrawn in United States."}
{"id":"CHEMBL446785","canonicalSmiles":"CC(/C=C/C=C(\\C)C(=O)O[C@@H]1O[C@H](CO[C@@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)[C@@H](O)[C@H](O)[C@H]1O)=C\\C=C\\C=C(C)\\C=C\\C=C(/C)C(=O)O[C@@H]1O[C@H](CO[C@@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)[C@@H](O)[C@H](O)[C@H]1O","inchiKey":"SEBIKDIMAPSUBY-RTJKDTQDSA-N","drugType":"Oligosaccharide","blackBoxWarning":false,"name":"CROCIN","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Crocetin Di(Beta-Gentiobiosyl)Ester","Crocetin di-gentiobiose ester","Crocin","Crocin 1"],"crossReferences":{"PubChem":["144205390","29216153"],"drugbank":["DB11874"],"chEBI":["79068"]},"count":1,"description":"Oligosaccharide drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL4594254","canonicalSmiles":"C(=C/[C@H]1CCNC1)\\c1cncnc1","inchiKey":"FNEHSHNEXMPCLJ-VWCDRPFISA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SIMPINICLINE","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["OC-02","Simpinicline","TC-6499","TC-6499-12","Tc-6499"],"childChemblIds":["CHEMBL4594377"],"count":2,"linkedTargets":{"rows":["ENSG00000160716","ENSG00000101204","ENSG00000117971","ENSG00000080644"],"count":4},"linkedDiseases":{"rows":["EFO_0000555","EFO_1000948"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL4594422","canonicalSmiles":"CCN1CCCC1CNC(=O)c1cc(S(=O)(=O)CC)c(NC)cc1OC","inchiKey":"NXKXZXNNWRYXRE-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"LB-102","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["LB-102","Lb-102"],"count":1,"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL4594481","drugType":"Unknown","blackBoxWarning":false,"name":"MEDI-547","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Medi-547"],"count":1,"description":"Unknown drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL4594575","drugType":"Antibody","blackBoxWarning":false,"name":"SABATOLIMAB","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["MBG-453","MBG453","Mbg 453","Mbg453","Sabatolimab"],"count":6,"description":"Antibody drug with a maximum clinical trial phase of III (across all indications) and has 6 investigational indications."}
{"id":"CHEMBL461522","canonicalSmiles":"Cc1c(N(C)CS(=O)(=O)O)c(=O)n(-c2ccccc2)n1C","inchiKey":"LVWZTYCIRDMTEY-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DIPYRONE","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":true,"isApproved":true,"withdrawnNotice":{"countries":["United Kingdom"," United States"," Grecia"," Suecia"," Nepal"," Zimbabwe"," Yemen"],"classes":["Hematological toxicity"," Immune system toxicity"],"year":1975},"tradeNames":["Diprofarn","Novaldin"],"synonyms":["Dipyrone"],"crossReferences":{"drugbank":["DB04817"],"chEBI":["62088"]},"childChemblIds":["CHEMBL487894","CHEMBL3989803"],"linkedTargets":{"rows":["ENSG00000073756","ENSG00000095303"],"count":2},"linkedDiseases":{"rows":["EFO_0005762","HP_0100806","EFO_1001412","EFO_1001463","EFO_0003821","HP_0001945","EFO_0000712","HP_0003419","EFO_0003843","EFO_0003964"],"count":10},"description":"Small molecule drug with a maximum clinical trial phase of IV. It was withdrawn in United Kingdom,  United States,  Grecia,  Suecia,  Nepal,  Zimbabwe and  Yemen initially in 1975 due to Hematological toxicity and  Immune system toxicity."}
{"id":"CHEMBL481931","canonicalSmiles":"CN1CC[C@H](N(C)C(=O)N2CC(c3cc(F)ccc3F)=C[C@@]2(CO)c2ccccc2)[C@H](F)C1","inchiKey":"MYBGWENAVMIGMM-GIFXNVAJSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"MK-0731","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["MK-0731"],"crossReferences":{"drugbank":["DB08037"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL489798","canonicalSmiles":"O=C1NC(=S)N[C@@]12O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O","inchiKey":"OEWLGQKSTDZKFN-WWHASAIZSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL489798","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB02964"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL495898","canonicalSmiles":"Oc1ccc(Cc2nnc3ccc(-c4ccccc4)nn23)cc1","inchiKey":"ZGJYGQLGSXWEMY-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL495898","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB08111"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL502384","canonicalSmiles":"C1CN1c1nc(N2CC2)nc(N2CC2)n1","inchiKey":"IUCJMVBFZDHPDX-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TRIETHYLENEMELAMINE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Tretamine","Triethylenemelamine"],"crossReferences":{"PubChem":["75085"],"Wikipedia":["Triethylenemelamine"],"drugbank":["DB14031"],"chEBI":["27919"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL518043","canonicalSmiles":"Cc1cc(C(=O)N2CCCCc3ccccc32)ccc1CNC(=O)N1CCC[C@H]1C(=O)N(C)C","inchiKey":"RUOLFWZIFNQQGH-DEOSSOPVSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"FEDOVAPAGON","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Fedovapagon","VA-106483"],"crossReferences":{"drugbank":["DB11734"]},"description":"Small molecule drug with a maximum clinical trial phase of II."}
{"id":"CHEMBL52011","canonicalSmiles":"OC[C@H]1O[C@@H](S[C@@H]2O[C@H](CO)[C@H](O)[C@H](O)[C@H]2O)[C@H](O)[C@@H](O)[C@H]1O","inchiKey":"SYKYBMOFPMXDRQ-ZFDCCPEWSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"THIODIGALACTOSIDE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Thiodigalactoside"],"crossReferences":{"drugbank":["DB04396"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL538937","canonicalSmiles":"COCCOc1cc(C)nc(N)n1","inchiKey":"VCJHOFUOIQHNBC-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL538937","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB08786"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL538940","canonicalSmiles":"NCc1ccc(-c2cccs2)s1","inchiKey":"FHYTVXBZSXZMGD-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL538940","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07094"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL549343","canonicalSmiles":"CNCc1ccccc1-c1cccs1","inchiKey":"MRKJJEJYTBOUTH-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL549343","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07196"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL571209","canonicalSmiles":"Cn1cc(C[C@@H](N)C(=O)O)c2ccccc21","inchiKey":"ZADWXFSZEAPBJS-SNVBAGLBSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"INDOXIMOD","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["D-1-Methyltryptophan","D-1MT","Indoximod","NLG-8189"],"crossReferences":{"PubChem":["536240"],"drugbank":["DB12827"]},"count":9,"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 9 investigational indications."}
{"id":"CHEMBL574817","canonicalSmiles":"Nc1ncnc2c1ncn2[C@@H]1O[C@H](COP(=O)(O)O)[C@@H](OP(=O)(O)O)[C@H]1O","inchiKey":"WHTCPDAXWFLDIH-KQYNXXCUSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL574817","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB01812"],"chEBI":["17985"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL587723","canonicalSmiles":"CCN1CCN(Cc2ccc(-c3cc4c(N[C@H](C)c5ccccc5)ncnc4[nH]3)cc2)CC1","inchiKey":"OONFNUWBHFSNBT-HXUWFJFHSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"AEE-788","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["AEE-788","AEE788","Aee 788","Aee-788","GNF-PF-5343","NVP-AEE-788","NVP-AEE788"],"crossReferences":{"Wikipedia":["AEE788"],"drugbank":["DB12558"]},"count":3,"linkedTargets":{"rows":["ENSG00000146648","ENSG00000128052","ENSG00000102755","ENSG00000141736"],"count":4},"linkedDiseases":{"rows":["EFO_0000519","EFO_0000311","EFO_1000158"],"count":3},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL599552","canonicalSmiles":"O=C1/C(=C2\\Nc3ccccc3C2=O)Nc2ccccc21","inchiKey":"COHYTHOBJLSHDF-BUHFOSPRSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"INDIGO","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["C.I.73000","Indigo","Indigofera tinctoria","NSC-8645"],"crossReferences":{"PubChem":["144205605","144209743","170465746","26756710"],"Wikipedia":["Indigo_dye"]},"count":5,"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 5 investigational indications."}
{"id":"CHEMBL706","canonicalSmiles":"CCCCCCCCCCCCCCCCO","inchiKey":"BXWNKGSJHAJOGX-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CETYL ALCOHOL","yearOfFirstApproval":1990,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Cetanol","Cetyl Alcohol","Cetyl alcohol","Hexadecanol"],"crossReferences":{"PubChem":["144205162","144210643","170465348","26754466","29215289","29215290"],"Wikipedia":["Cetyl_alcohol"],"drugbank":["DB09494"],"chEBI":["16125"]},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1990."}
{"id":"CHEMBL807","canonicalSmiles":"CC12CC3CC(C)(C1)CC(N)(C3)C2","inchiKey":"BUGYDGFZZOZRHP-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"MEMANTINE","yearOfFirstApproval":2003,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["D-145","DRG-0267","Memantine","Namenda"],"crossReferences":{"DailyMed":["memantine%20hydrochloride"],"PubChem":["104171191","144203750","170464999","26751885","50104569","90341818"],"Wikipedia":["Memantine"],"drugbank":["DB01043"],"chEBI":["64312"]},"childChemblIds":["CHEMBL1882685","CHEMBL1699"],"count":34,"approvedIndications":["HP_0000726"],"linkedTargets":{"rows":["ENSG00000183454","ENSG00000273079","ENSG00000116032","ENSG00000161509","ENSG00000105464","ENSG00000176884","ENSG00000198785"],"count":7},"linkedDiseases":{"rows":["EFO_0004190","EFO_0002610","EFO_0009386","MONDO_0002009","HP_0200134","EFO_0000249","HP_0001268","EFO_0003768","EFO_0003757","HP_0012228","EFO_0003829","MONDO_0002046","HP_0100543","EFO_0002690","EFO_0000253","MONDO_0004681","EFO_0000692","EFO_0005762","EFO_0003888","EFO_0003756","EFO_0005203","EFO_0002508","EFO_0003758","HP_0002381","Orphanet_399","EFO_1001488","EFO_0007328","EFO_0004699","EFO_0003108","Orphanet_282","EFO_1001998","EFO_0004240","EFO_0005687","EFO_0003096","Orphanet_232","HP_0000726","EFO_1001465","EFO_0009267","EFO_0000289","MONDO_0002050","EFO_0000712","EFO_0000326","EFO_0001064","EFO_0004242","EFO_0005230","HP_0001337","HP_0002140","EFO_0004329","EFO_0001358","EFO_0001073","EFO_0003843","EFO_0003885","EFO_0001072","MONDO_0002491","EFO_0005611","MONDO_0043510","MONDO_0024880","EFO_0005411","EFO_0000519"],"count":59},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2003 and is indicated for dementia and has 33 investigational indications."}
{"id":"CHEMBL961","canonicalSmiles":"CCN(CC)C(=S)S","inchiKey":"LMBWSYZSUOEYSN-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DITIOCARB","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Diethyldithiocarbamate"],"crossReferences":{"PubChem":["29218086"],"drugbank":["DB02520"]},"childChemblIds":["CHEMBL3185333","CHEMBL107217","CHEMBL3182813"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL98350","canonicalSmiles":"O=c1cc(N2CCOCC2)oc2c(-c3ccccc3)cccc12","inchiKey":"CZQHHVNHHHRRDU-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"LY-294002","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["LY-294002"],"crossReferences":{"PubChem":["103905473","11111398","11113937","124880604","124880606","124880607","26752090","26752091","525433","90341244"],"Wikipedia":["LY294002"],"drugbank":["DB02656"],"chEBI":["65329"]},"childChemblIds":["CHEMBL1398499"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
